Patent details
EP3820461 Title: USE OF ASPARAGINASE IN COMBINATION WITH GSK3A INHIBITION FOR TREATING CANCER
Basic Information
- Publication number:
- EP3820461
- PCT Application Number:
- US2019041555
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP198334161
- PCT Publication Number:
- WO2020014581
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF ASPARAGINASE IN COMBINATION WITH GSK3A INHIBITION FOR TREATING CANCER
- French Title of Invention:
- UTILISATION DE L'ASPARAGINASE COMBINÉE AVEC L'INHIBITION DE GSK3A POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- VERWENDUNG VON ASPARAGINASE ZUSAMMEN MIT HEMMUNG VON GSK3A ZUR BEHANDLUNG VON KREBS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 06/02/2026
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 13/03/2026
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/01/2026
- Unitary Effect Registration Date:
- 13/03/2026
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 12/07/2019
- Grant date:
- 07/01/2026
- EP Publication Date:
- 19/05/2021
- PCT Publication Date:
- 16/01/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/01/2026
- EP B1 Publication Date:
- 07/01/2026
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 12/07/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/12/2025
- Name:
- The Children's Medical Center Corporation
- Address:
- 55 Shattuck Street, Boston, MA 02115, United States (US)
Inventor
1
- Name:
- HINZE, Laura
- Address:
- United States (US)
2
- Name:
- GUTIERREZ, Alejandro
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201862697053 P
- Priority Date:
- 12/07/2018
- Priority Country:
- United States (US)
2
- Priority Number:
- 201862751129 P
- Priority Date:
- 26/10/2018
- Priority Country:
- United States (US)
3
- Priority Number:
- 201962839912 P
- Priority Date:
- 29/04/2019
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 38/50; A61K 31/167; A61K 31/415; A61K 31/4015; A61K 31/404; A61K 31/437; A61P 35/00; A61K 31/506; A61K 31/5517; A61K 31/7105; A61K 31/15; A61K 31/5377;
Publication
European Patent Bulletin
1
- Issue number:
- 202602
- Publication date:
- 07/01/2026
- Description:
- Grant (B1)
2
- Issue number:
- 202612
- Publication date:
- 18/03/2026
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202616
- Publication date:
- 15/04/2026
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|